Expanding Innovations recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its X-PAC expandable lateral cage system (X-PAC LLIF).
The approval marks a significant addition to the company’s expandable product portfolio which also includes the company’s flagship X-PAC expandable posterior cage system (X-PAC TLIF).
K. Brandon Strenge of the Orthopaedic Institute of Western Kentucky (Paducah, USA), said: “The X-PAC expandable lateral cage system is the first implant I have seen that addresses the core principals of lateral lumbar interbody fusion. The maximised posterior expansion facilitates indirect decompression, the open architecture ensures a bridging bone fusion, and the multiple lordotic options allow proper implant selection for restoration of sagittal balance.
“These benefits, coupled with the ability to insert the cage at a nominal height, then dial it up via controlled expansion, make X-PAC Lateral an exciting and beneficial technology to offer my patients moving forward.”